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ABSTRACT   16 
Ethanol extracts (EE) from fenugreek and quinoa seeds with different total content of inhibitory 17 
compounds (TIC, total saponin plus phenolic) were prepared with and without concentration of TIC 18 
(CEE –concentrated EE-, and EE, respectively). Their inhibitory activity on pancreatic lipase and α-19 
amylase was assessed by traditional in vitro methods (with or without orbital shaking), and by 20 
simulating intestinal digestion. 21 
CEE contained higher contents of TIC than EE, being fenugreek superior to quinoa (p < 0.001). The 22 
extracts inhibited enzymes in a dose-dependent manner, CEE extracts being stronger (fenugreek for 23 
lipase -p = 0.009-, and quinoa for α-amylase -p < 0.001-). Shaking did not impact the activity. 24 
Intestinal conditions worsened the inhibition of lipase, but slightly catalyzed the α-amylase. Longer 25 
times of reaction worsened activities. 26 
The importance of assessing the inhibitory activity of extracts under simulated intestinal conditions 27 
is concluded, being fenugreek more interesting than quinoa, especially against pancreatic lipase.  28 
 29 
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 32 
 33 
Chemical compounds studied in this article: Orlistat (PubChem CID: 3034010); acarbose 34 
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1. Introduction 39 
The metabolic syndrome (MetS), characterized by the combination of at least three of the 40 
cardiovascular risk factors (abdominal obesity, dyslipidemia, hypertension and hyperglycemia), 41 
currently has a high prevalence across Europe with an age-associated increase, and is an early sign 42 
for future development of chronic diseases such as obesity and/or type 2 diabetes (Scuteri et al., 43 
2015). Together with dietary and lifestyle modifications, the treatment of MetS-related risk factors 44 
is mainly based on pharmacological approaches. In this way, one of the popular strategies in the 45 
development of drugs against the MetS is the search for inhibitors that interfere with the digestive 46 
enzymes responsible for the hydrolysis and absorption of macronutrients, such as carbohydrates and 47 
triglycerides (de la Garza, Milagro, Boque, Campión, & Martínez, 2011). Thus, glycemic index 48 
imbalance and glucose intolerance can be improved by inhibiting enzymes involved in carbohydrate 49 
digestion, such as pancreatic α-amylase, which degrades polysaccharides into oligosaccharides and 50 
disaccharides, and brush border α-glucosidase, which degrades the latter into monosaccharides. 51 
However, most of the synthetic inhibitors commercially available, such as acarbose, have strong 52 
amylase and glucosidase inhibitory properties, causing an excessive inhibition of amylase activity 53 
and a subsequent abnormal fermentation of undigested saccharides in the colon (Ercan & El, 2016; 54 
Nagmoti & Juvekar, 2013). Therefore, the preferred strategy to control the release of glucose from 55 
disaccharides in the gut seems to be a moderate amylase inhibition together with strong glucosidase 56 
inhibition (Ercan & El, 2016). Likewise, the inhibition of the human pancreatic lipase, the main 57 
enzyme responsible for the hydrolysis of triacylglycerols into monoacylglycerols and free fatty 58 
acids, is a popular therapeutic approach against overweight, obesity and obesity-related diseases. 59 
Currently, the synthetic product Orlistat is clinically used as a pancreatic lipase inhibitor, although 60 
side effects such as flatulence, diarrhea or dyspepsia are also commonly developed (Marrelli, 61 
Conforti, Araniti, & Statti, 2016; Seyedan, Alshawsh, Alshagga, Koosha, & Mohamed, 2015). Such 62 
side effects described for both commercial inhibitors are the main reasons for the continuous 63 
research of novel enzyme inhibitors, preferably from natural sources versus the synthetic ones.  64 
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Within natural sources, vegetables and plants are the most popular sources containing bioactive 65 
compounds of a wide diverse chemical nature that are well-known for their biological activities, 66 
such as antiinflamatory, antihypertensive, antioxidant, anticarcinogenic, antidiabetic or antiobesity. 67 
Within these compounds, those with inhibitory activity against digestive enzymes have been also 68 
described. Specifically, the most common compounds that are found in different plant species for 69 
which have been described enzyme inhibition activities are terpenes, saponins or polyphenols, being 70 
the last two the widest groups of natural inhibitors against digestive enzymes (Birari & Bhutani, 71 
2007; Buchholz & Melzig, 2015; Marrelli et al., 2016; Navarro del Hierro, Herrera, Fornari, 72 
Reglero, & Martin, 2018; Xiao, Ni, Kai, & Chen, 2013). 73 
Saponins consist of a triterpenoid or steroid non-polar aglycone attached to one or more hydrophilic 74 
oligosaccharide moieties through an ether or ester glycosidic linkage. Triterpenoid saponins have 75 
been identified in legumes, quinoa seeds, ginseng roots, quillaja bark or liquorice roots, whereas 76 
steroid saponins have been found in fenugreek seeds, yucca, ginseng roots, asparagus or oats 77 
(Güçlü-Üstündağ & Mazza, 2007; Makkar, Siddhuraju, & Becker, 2007). Although the inhibitory 78 
activity of saponins from many of these sources has been intensively explored, the potential of other 79 
saponin sources, such as edible seeds, has not been so extensively elucidated, especially saponin-80 
rich extracts produced from edible seeds as legumes or quinoa. In this sense, fenugreek seeds are 81 
legumes known to contain high levels of steroidal saponins, whereas the seeds of the pseudo-cereal 82 
quinoa have been described as sources of triterpenoid saponins (Arivalagan, Gangopadhyay, & 83 
Kumar, 2013; Medina-Meza, Aluwi, Saunders, & Ganjyal, 2016).  84 
Polyphenols are the most widespread and common bioactive constituents in plants, and represent 85 
the most abundant antioxidants in the human diet. Polyphenols contain at least one aromatic ring 86 
with one or more hydroxyl groups in addition to other substituents, and they can be divided into 15 87 
major classes according to their chemical structures (Xiao et al., 2013). Together with the specific 88 
activity as inhibitors of digestive enzymes, a wide range of biological effects have been described 89 
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for both compounds, such as hypocholesterolemic, antiinflammatory, antitumor, 90 
immunomodulatory or antibacterial activities (Li et al., 2014; Singh, Singh, Singh, & Kaur, 2017).  91 
Taking into consideration the potential of these two types of molecules as bioactive agents, great 92 
efforts are being made to obtain saponin or polyphenol rich-extracts with inhibitory activities on the 93 
main digestive enzymes. However, most of the previous studies on these inhibitors have been 94 
mainly focused on the production of either saponin-rich extracts or polyphenol-rich extracts, but the 95 
production of extracts with a simultaneous combination of both potential inhibitors within the same 96 
extracts has been less scarcely explored and might be of interest. In this way, we have recently 97 
demonstrated that the ultrasound-assisted extraction from different edible seeds (quinoa, lentil, 98 
fenugreek, soybean and lupin) favors the obtaining of saponin-rich ethanol extracts with an 99 
interesting content of polyphenols, although the exploration of further concentration procedures 100 
might be of interest for obtaining even richer saponin extracts with stronger bioactivities (Navarro 101 
del Hierro, Herrera, García-Risco, et al., 2018). Additionally, in such study, fenugreek and quinoa 102 
were the richest extracts in saponins plus phenolic compounds, so the evaluation of the potential of 103 
these extracts that combined both bioactive molecules on the inhibition of pancreatic lipase and α-104 
amylase might be of interest.   105 
Concerning the inhibitory study of compounds, it is important to remark that contradictory results 106 
about the inhibitory activities from saponins and polyphenols can be found in the different studies, 107 
since either positive inhibition of digestive enzymes has been shown, or either such an effect has 108 
not always been clearly demonstrated. These contradictory results might be related, among other 109 
factors, to differences among the methodologies used to determine such activity. Thus, most studies 110 
have assessed the in vitro inhibitory activity by merely replicating the enzymatic reaction, that is, 111 
combining substrate, enzyme and inhibitor in a proper buffer (Tucci, Boyland, & Halford, 2010). 112 
However, in order to clearly understand the magnitude and potential of an inhibitor after its 113 
presumable oral intake, it is essential to reproduce the environment of the gastrointestinal tract as 114 
possible, as the complexity of the in vivo physiological conditions might affect the global enzymatic 115 
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result (Lee, Mohd Esa, & Loh, 2015). In agreement, Vinarova et al. (2015) carried out the in vitro 116 
gastrointestinal digestion of several fats in presence of diverse saponin extracts and reported a lack 117 
of effect on the hydrolysis of triglycerides, regardless of the saponin concentration. Ercan & El 118 
(2016) evaluated the inhibitory activity of saponin extracts from chickpea and Tribulus terrestris 119 
against glucosidase and amylase after simulation of intestinal digestion by in vitro conditions. Such 120 
activity after the in vitro digestion was lower than prior to digestion, which was attributed to a likely 121 
effect of the digestion process, temperature or pH of the media on the activity of the compounds. 122 
Thus, when evaluating the inhibitory activity of extracts and compounds against digestives 123 
enzymes, more complex factors closer to an in vivo situation, might also need to be considered, 124 
such as temperature, time of reaction, shaking during the process, or composition of the reaction 125 
media, as such activity could be either over or underestimated. 126 
The present study aims to obtain different extracts with different content of potential inhibitors, 127 
namely saponins and polyphenols, from two edible seeds, fenugreek (as a representative source of 128 
steroid-like saponins) and quinoa (as a representative source of triterpenoid-like saponins). Then, 129 
the inhibitory effect of such extracts on lipase and α-amylase enzymes was assessed by comparing 130 
three in vitro procedures where different factors including shaking, time of digestion, and medium 131 
composition, were taken into consideration. Specifically, the traditional in vitro method of 132 
inhibition measurement, either with or without shaking, and a more complex method simulating 133 
intestinal conditions, were compared.  134 
 135 
2. Materials and methods 136 
2.1 Reagents and Materials 137 
Seeds of red quinoa (Chenopodium quinoa) as triterpenoid-like saponins, were purchased from Hijo 138 
de Macario Marcos (Salamanca, Spain). Fenugreek (Trigonella foenum-graecum), as steroidal-like 139 
saponins, were from Murciana de Herboristeria (Murcia, Spain).  140 
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Lipase from porcine pancreas (L3126), α-amylase from porcine pancreas (A3176), 4-141 
methylumbelliferyl oleate (4-MUO) (75164), starch from potato (S2004), lugol solution (62650), 142 
acarbose (PHR1253), Orlistat (PHR1445), Dulbecco’s Phosphate Buffered Saline (PBS) (59300C), 143 
bile salts (B8756), phosphatidyl choline from egg yolk (61771), sodium chloride (746398), calcium 144 
chloride (746495), Trizma base (T1503) and maleic acid (M0375), were from Sigma-Aldrich 145 
Chemie GmbH (Steinheim, Germany). Soyasaponin I (S9951), protodioscin (G0299), catechin 146 
(43412) were from Sigma-Aldrich Chemie GmbH (Steinheim, Germany). Absolute ethanol 147 
(131086.1214) and n-butanol (131082.1611) were from Panreac-AppliChem (Spain), 95% n-hexane 148 
(6752-25) was from Macron (Poland). 149 
 150 
2.2 Obtention of the extracts 151 
Seeds were ground in a knife mill (Grindomix GM200 RETSCH) at 10000 rpm for 1 min. The 152 
resulting powder was sieved in a vertical sieve (CISA Cedacería Industrial, España) in order to 153 
obtain fractions with a particle size between ≤ 250 and > 100 µm. Extraction was based on Navarro 154 
del Hierro, Herrera, García-Risco, et al. (2018) with modifications. Firstly, samples were defatted 155 
with hexane at a ratio of sample to solvent of 1:5 (w/v) for 2 min by direct sonication (Branson 156 
SFX250 Digital Sonifier, Branson Ultrasonics, USA) with an ultrasonic probe (1/2” diameter, 157 
output sonication amplitude of 60%). The mixture was then centrifuged at 4000 rpm for 5 min. 158 
Supernatant was discarded and the precipitate was defatted again under the same conditions. After 159 
defatting, the precipitate was extracted with ethanol at a ratio of sample to solvent of 1:10 (w/v) for 160 
15 min by direct sonication (Branson SFX250 Digital Sonifier, Branson Ultrasonics, USA) with an 161 
ultrasonic probe (1/2” diameter, output sonication amplitude of 60%), and the temperature during 162 
the process was kept under 40 ºC. The mixture was filtered under vacuum and dried using a rotary 163 
evaporator. The resulting ethanol extracts (EE) were stored at -20 ºC until further use. Extractions 164 
were performed at least in duplicate. 165 
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A second extract was produced from both seeds as concentrated ethanol extract (CEE). The aim of 166 
this procedure was to obtain a higher enrichment of saponins of the EE, which is frequently 167 
performed by a liquid-liquid procedure with aqueous butanol (Chan, Iqbal, Khong, Ooi, & Ismail, 168 
2014; Güçlü-Üstündağ & Mazza, 2007; Pham, Vuong, Bowyer, & Scarlett, 2017). Thus, starting by 169 
the same procedure to obtaining the EE, an additional concentration step was performed based on 170 
Chan, Iqbal, Khong, Ooi, & Ismail (2014) with modifications. Briefly, after obtaining the EE, 50 171 
mL of water and 100 mL of n-butanol were added, vortexed for 1 min and centrifuged at 4500 rpm 172 
for 10 min. The upper supernatant of n-butanol was filtered and the lower supernatant was extracted 173 
again with water and butanol under the same conditions. The collected upper supernatants were 174 
dried using a rotary evaporator and the resulting CEE were stored at -20 ºC until further use. 175 
Extractions were performed at least in duplicate. 176 
 177 
2.3 HPLC analysis of saponins and phenolic compounds 178 
Quantification of total saponins and total phenolic compounds was performed on an Agilent HPLC 179 
1260 Infinity series system coupled to a photodiode-array detector (Agilent Technologies Inc., 180 
Santa Clara, CA) equipped with an ACE 3 C18-AR column (150mm x 4.6mm, 3 μm particle size) 181 
protected by a guard column. Samples were dissolved in methanol at 10 mg/mL and the injection 182 
volume was 20 μL. The compounds occurring in the extracts were monitored at 205 nm, and UV 183 
spectra were recorded from 190 to 700 nm. Chromatographic separation was achieved at 25 ºC 184 
using 0.05% TFA in water (Phase A) and 0.05% TFA in acetonitrile (Phase B) at a flow rate of 0.4 185 
mL/min as follows: 0 min: 95% A; 20 min: 5% A; 45 min: 5% A; 46 min 95% A; 50 min: 95% A.  186 
Identification of saponins was previously confirmed in an Agilent 6120 HPLC-MS by pure 187 
commercial standards or by comparison with mass spectra from the literature. The same flow and 188 
gradient conditions previously described were used for the HPLC-MS analyses. The rest of the 189 
conditions were as follows, according to Mad, Sterk, Mittelbach, & Rechberger (2006): MS 190 
ionization mode with APcI+/- between 30 and 1500 Da range mass. Nebulizing/drying gas at a flow 191 
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rate of 5 L/min, 350 ºC and 20 psi. The vaporizer temperature was set at 250 ºC, the capillary 192 
voltage was set to 2000 and 4000 V, and fragmentor voltage was set at 40 V. Spectra were obtained 193 
over m/z 300-1500. On the other hand, in case of phenolic compounds, these were confirmed 194 
according to their UV spectra and compared with pure commercial standards. 195 
Total saponin content (TSC) was calculated as g of protodioscin equivalents/100 g of extract for 196 
fenugreek, and g of soyasaponin I/100 g of extract for quinoa, each of these standards representing 197 
steroid-like or triterpenoid-like saponins, respectively. Total phenolic content (TPC) was calculated 198 
as g of catechin equivalents/100 g of extract. Finally, for comparative purposes between the 199 
extracts, a value defined as total content of inhibitory compounds (TIC) was estimated as the sum of 200 
TSC and TPC. It should be remarked that, according to this given definition of TIC, this value does 201 
not consider other potential and unknown phytochemicals of the extracts with potential inhibitory 202 
activity, but only saponins and phenolic compounds.     203 
 204 
2.4 Enzyme inhibition assays 205 
2.4.1 General 206 
Both lipase and α-amilase inhibition assays were performed by incubation of the substrate, enzyme 207 
and extract at 37 ºC, under three different conditions: A) traditional method, that is, static 208 
incubation, using PBS as buffer; B) traditional method with shaking incubation; and C) simulation 209 
of intestinal conditions, that is, shaking incubation using a digestion buffer (Trizma-Maleic 100 210 
mM, pH 7.5, 0.15 M NaCl, and 5.1 mM CaCl2), containing bile salts (7.8 mg/mL) and lecithin (3.12 211 
mg/mL) according to the model of in vitro intestinal digestion of Martin et al. (2016). 212 
 213 
2.4.2 Pancreatic lipase inhibition assay 214 
The inhibitory activity of each extract against pancreatic lipase was measured by using 4-MUO as 215 
substrate, according to Sugiyama et al. (2007) with modifications. Reaction mixture consisted of 1 216 
mL of extract solution in buffer at different concentrations, 1 mL of freshly-prepared pancreatic 217 
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lipase at 1 mg/mL (0.01 g of lipase in 10 mL of buffer, stirred for 10 min and centrifuged at 4000 218 
rpm for 10 min), and lastly, 2 mL of 4-MUO solution at 0.1 mM in buffer.  219 
At least, five different concentrations of extracts were tested. Reactions at each concentration were 220 
prepared in triplicate. Control samples in absence of extracts were prepared following the same 221 
procedure, also in triplicate. Control of extracts at each concentration of each extract, in absence of 222 
lipase and substrate, were also prepared in triplicate.   223 
The reaction mixture was placed at 37 ºC in an orbital incubator, either without or with shaking 224 
(250 rpm), depending on the condition assayed. Three aliquots of 150 µL were taken at 20 and 60 225 
min of reaction and the amount of 4-MUO hydrolyzed by lipase was measured in a 96-well 226 
microplate using a fluorescence microplate reader (Polarstar Galaxy, BMG Labtechnologies) at an 227 
excitation wavelength of 350 ±10 nm and an emission wavelength of 450 nm.  228 
The inhibition of pancreatic lipase activity was calculated as follows: 229 
𝑰𝒏𝒉𝒊𝒃𝒊𝒕𝒊𝒐𝒏  % = 𝟏𝟎𝟎 −   
𝑭𝒆𝒙𝒕𝒓𝒂𝒄𝒕 𝒔𝒂𝒎𝒑𝒍𝒆 − 𝑭𝒆𝒙𝒕𝒓𝒂𝒄𝒕 𝒄𝒐𝒏𝒕𝒓𝒐𝒍
𝑭𝒄𝒐𝒏𝒕𝒓𝒐𝒍 𝒔𝒂𝒎𝒑𝒍𝒆
  ×  𝟏𝟎𝟎  
 230 
Where Fextract sample is the fluorescence of the reactions with added extract, Fextract control is the 231 
fluorescence of the control of extracts, and Fcontrol sample is the fluorescence of the reactions without 232 
extract.  233 
Finally, a logarithmic regression curve was established to calculate IC50 values (mg/mL), defined as 234 
the concentration of the extract that inhibited 50% the activity of the pancreatic lipase.  235 
Preparations using the commercial inhibitor of pancreatic lipase, namely Orlistat, were performed 236 
following the same procedure, in order to evaluate the magnitude of the results obtained for the 237 
extracts in case of the experiments performed under the conditions of simulation of intestinal 238 
digestion. 239 
 240 
2.4.3 α-amilase inhibition assay 241 
The inhibitory activity of each extract against α-amylase was measured by using starch as substrate, 242 
using the Caraway-Somogyi iodine/potassium iodide method with slight modifications, according 243 
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to Afiukwa, Ibiam, Edeogu, Nweke, & Chukwu (2009) and Zengin (2016). Briefly, reaction 244 
mixture consisted of 1 mL of extract solution in buffer at different concentrations and 1 mL of α-245 
amylase solution at 0.4 mg/mL in buffer. This mixture was placed in an orbital incubator at 37 ºC 246 
for 10 min. After pre-incubation, the reaction was initiated by the addition of 1 mL of potato starch 247 
solution (0.5% in water heated at 100 ºC for 15 min) tempered at 37 ºC.  248 
At least, five different concentrations of extracts were tested. Reactions at each concentration were 249 
prepared in triplicate. Control samples in absence of extracts were prepared following the same 250 
procedure, also in triplicate. Control of extracts at each concentration of each extract, in absence of 251 
α-amylase and substrate, were also prepared in triplicate. Finally, control of substrate, in absence α-252 
amylase and extracts were also prepared.  253 
The reaction mixture was placed at 37 ºC in an orbital incubator, either without or with shaking 254 
(250 rpm), depending on the condition assayed. Three aliquots of 150 µL were taken at 20 and 60 255 
min of reaction and placed in a 96-well microplate. Then, 100 µL of indicator (lugol) were added 256 
and absorbance was measured at 585 nm.   257 
The inhibition of α-amylase activity was calculated as follows: 258 
𝑰𝒏𝒉𝒊𝒃𝒊𝒕𝒊𝒐𝒏  % = 𝟏𝟎𝟎 −   
𝑨𝒔𝒖𝒃𝒔𝒕𝒓𝒂𝒕𝒆 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 −  𝑨𝒆𝒙𝒕𝒓𝒂𝒄𝒕 𝒔𝒂𝒎𝒑𝒍𝒆 − 𝑨𝒆𝒙𝒕𝒓𝒂𝒄𝒕 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 
𝑨𝒔𝒖𝒃𝒔𝒕𝒓𝒂𝒕𝒆 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 − 𝑨𝒄𝒐𝒏𝒕𝒓𝒐𝒍 𝒔𝒂𝒎𝒑𝒍𝒆
  ×  𝟏𝟎𝟎  
 259 
Where Asubstrate control is the absorbance of the control of substrate, Aextract sample is the absorbance of 260 
the reactions with added extract, Aextract control is the absorbance of the control of extracts, and Acontrol 261 
sample is the absorbance of the reactions without extract.  262 
Preparations using the commercial inhibitor of α-amylase, namely acarbose, were performed 263 
following the same procedure, in order to evaluate the magnitude of the results obtained for the 264 
extracts in case of the experiments performed under the conditions of simulation of intestinal 265 
digestion. 266 
 267 
Statistical analysis 268 
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Statistical analyses were performed by means of the general linear model procedure of the SPSS 269 
24.0 statistical package (SPSS Inc., Chicago, IL, USA) by one-way analysis of variance. 270 
Differences were considered significant at P ≤ 0.05. Post-hoc Tukey’s tests were performed in order 271 
to establish significant differences.  272 
 273 
3. Results and discussion 274 
3.1 Saponin and phenolic content of the extracts   275 
Different ethanol extracts (EE) and concentrated ethanol extracts (CEE) of fenugreek and quinoa 276 
seeds were produced by ultrasound-assisted extraction, with the purpose of obtaining extracts with 277 
different content of saponins and phenolic compounds and, hence, different content of potential 278 
inhibitor compounds of digestive enzymes. Table 1 presents the TSC, TPC and TIC of both EE and 279 
CEE from the two studied seeds. On the one hand, regardless of the procedure of extraction, 280 
fenugreek granted by far higher contents of saponins and phenolic compounds than quinoa (p < 281 
0.001). Thus, as mean value, saponin content of fenugreek extracts was around 12 g/100 g of 282 
extract, compared to 0.3 g/100 g of extract of quinoa; and, as mean value, phenolic content of 283 
fenugreek extracts was around 1 g/100 g of extract, compared to 0.1 g/100 g of extract of quinoa.  284 
On the other hand, regardless of the seed, and although it was not significant (p > 0.05), the results 285 
showed that CEE tended to have a slight higher content of saponins than EE, although it was more 286 
noticeable in the quinoa extracts (70% increment of TSC for CEE respect to EE) than in those from 287 
fenugreek (28% increment of TSC for CEE respect to EE). This trend to a concentration effect of 288 
saponins with butanol was not clearly observed in case of TPC. Thus, TPC only seemed to be 289 
higher in CEE than EE for quinoa (80% increment of TPC for CEE respect to EE), whereas both EE 290 
and CEE from fenugreek displayed very similar values. Therefore, these results might suggest that 291 
the concentration procedure of the extracts with butanol, typically performed in the literature for 292 
obtaining saponin-rich extracts (Chan et al., 2014; Pham et al., 2017), might lead to extracts with an 293 
effective enrichment in saponins from the assayed seeds, but with variable modifications in the 294 
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phenolic content, mainly depending on the source, and likely depending on the chemical nature of 295 
the different phenolic compounds and their affinity for butanol.  296 
When considering the estimated value of TIC as the sum of TSC and TPC, the previously described 297 
differences between seeds reflected a final value of total inhibitors content clearly superior for 298 
fenugreek extracts than quinoa extracts (around 13 g/100 and 0.3 g/100 g, respectively). In any 299 
case, it is important to remark that, concerning the contribution of each type of inhibitor to the TIC 300 
value, it was clear that total saponins accounted for the major component, although slight 301 
differences were found between fenugreek and quinoa extracts. Thus, saponins and phenolic 302 
compounds from fenugreek extracts accounted for 91% and 9% of the TIC, respectively; whereas 303 
saponins and phenolic compounds from quinoa extracts accounted for 80% and 20% of the TIC, 304 
respectively.  305 
As summary, the obtained results suggested that the fenugreek extracts appeared to be more 306 
interesting than the ones from quinoa as potential extracts against the activity of digestive enzymes 307 
if considering the total amount of inhibitor compounds as saponins and phenolic compounds. 308 
Furthermore, the concentration of the EE in potential inhibitors compounds was successfully 309 
achieved. Nevertheless, since the enrichment of the extracts was not remarkable, further studies 310 
might be of interest in order to explore other different conditions of extraction and/or concentration, 311 
in order to reach higher enrichments in total inhibitor compounds. Additionally, it would be also of 312 
interest to explore whether the applied procedure of concentration might also enrich the extracts in 313 
other compounds with inhibitory activity different to saponins and phenolic compounds.    314 
 315 
3.2 Inhibitory effect against pancreatic lipase  316 
3.2.1 Traditional method of in vitro inhibitory effect 317 
After confirming that the different extracts from the different seeds showed interesting and diverse 318 
content of inhibitor compounds, all the extracts were tested as potential pancreatic lipase inhibitors. 319 
Firstly, the inhibitory activity of the EE and CEE from fenugreek and quinoa was evaluated under 320 
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the traditional conditions typically described in the scientific literature. Although the traditional 321 
conditions can be variable, one of the most popular method is characterized by a simple in vitro 322 
incubation of the lipase enzyme with a fluorogen lipid substrate, in presence of the tested inhibitor, 323 
and in a proper phosphate buffer at 37 ºC for 20 min. At the end of reaction, the fluorescence due to 324 
the released fluorogen group from the substrate is measured, and the comparison with the 325 
fluorescence measured in absence of inhibitor allows to estimate the inhibitory activity (Podsędek, 326 
Majewska, & Kucharska, 2017; Zhang et al., 2015).  327 
As first and important finding, all the assayed extracts showed the ability to inhibit the pancreatic 328 
lipase activity, and in a dose-dependent manner, allowing to estimate an inhibition of 50% of the 329 
activity, as shown in Figure 1. However, interesting differences in this bioactivity were found 330 
between seeds and procedure of extraction. On the one hand, regardless of the procedure of 331 
extraction, a significant effect of the seed factor on the IC50 value was obtained (p = 0.003). Thus, 332 
the mean IC50 value for fenugreek extracts was significantly lower than the mean IC50 value of 333 
quinoa. Therefore, the inhibitory activity from fenugreek extracts was, as mean, 10 folds higher 334 
than that of quinoa, indicating a strongest inhibitory activity for fenugreek extracts.  335 
Concerning the effect of the extraction/concentration procedure of the extracts, a significant effect 336 
was also found on the IC50 values (p = 0.009). Thus, regardless of the seed, the CEE extracts 337 
showed significant lower IC50 values than the EE extracts. Therefore, in general, the inhibitory 338 
activity from CEE extracts was around 20 folds higher than that of the EE extracts, indicating a 339 
strongest inhibitory activity for CEE. Therefore, taking into account the effect of both factors on the 340 
IC50 value, namely the seed and the extraction/concentration procedure, it was concluded that the 341 
most efficient inhibitory extract of pancreatic lipase was the CEE from fenugreek (IC50 = 0.07 342 
mg/mL), whereas the less efficient inhibitory extract was the EE from quinoa (IC50 = 2.81 mg/mL) 343 
(Figure 1).   344 
These differences obtained due to both the seeds and the extraction/concentration procedure could 345 
be related to the content of saponins and phenolic compounds of the extracts. In fact, as shown in 346 
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Figure 2, a noticeable trend was observed to lower IC50 values as the value of TIC increased, for 347 
both fenugreek and quinoa extracts (Figure 2.a and 2.b, respectively). Therefore, this would suggest 348 
that a higher value of TIC of the CEE extracts from both seeds might be one of the factors that 349 
would cause a better inhibitory activity of these extracts against pancreatic lipase. Nevertheless, 350 
further studies would be necessary in order to confirm these results, since the concentration 351 
procedure of the extracts might also cause the potential concentration of other compounds of 352 
different chemical nature whose contribution to the inhibitory activity would need to be elucidated. 353 
In any case, in agreement with the present results, Oishi et al. (2007) also found that the butanol 354 
fraction (saponin fraction) of an aqueous methanol extract of Momordica charantia displayed a 355 
higher lipase inhibition than the water fraction due to the richness of saponins in the first fraction. 356 
Additionally, these authors attributed the inhibitory effect of saponins to their ability to bind to the 357 
substrate, causing a possible reduction in the contact area between the substrate and lipase and 358 
indirectly inhibiting the action of the enzyme. 359 
In the case of the seeds evaluated in this work, the effect of fenugreek and quinoa extracts on lipase 360 
inhibition has been very scarcely explored to date. Chaubey et al. (2018) have recently observed 361 
that the IC50 value of an ethanolic extract of fenugreek was 2.4 mg/mL. As difference, p-nitrophenol 362 
was used as substrate and absorbance was measured after 10 min of incubation. Tang et al. (2016) 363 
evaluated the effect of an alkaline-hydrolyzable bound phenolic fraction obtained from red quinoa 364 
seeds and found a IC50 value of 10 mg/mL. These authors used 4-MUO as substrate, although the 365 
reaction was prolonged for 1 hour. The abovementioned values in both seeds widely differ from the 366 
ones obtained in this work, probably due to factors such as the different composition of the extracts 367 
or the different method conditions. 368 
 369 
3.2.2 Traditional method of in vitro inhibitory effect under shaking 370 
The traditional method of in vitro measurement of inhibition of pancreatic lipase is typically 371 
performed under static conditions, according to most of the scientific literature reviewed. Therefore, 372 
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this was the procedure performed in the previous section 3.2.1. However, in order to simulate an in 373 
vivo enzymatic reaction as the intestinal lipolysis, and to test the potential inhibitory activity of 374 
presumably orally ingested compounds, we consider that, at least, some kind of movement of the 375 
media should be performed, since the intestinal tract is not a static environment, and the impact of 376 
this movement on the enzymatic reactions or inhibitory activities should be considered. 377 
Additionally, we consider that is especially relevant when complex extracts of difficult aqueous 378 
solubility as the assayed are tested. In these cases, it is frequent to find different procedures in the 379 
literature to enhance the solubility of the extracts in the reaction media, mainly by the help of 380 
addition of minor amounts of organic solvents that favors the perfect solubility of the extracts. 381 
However, in the present study, we preferred to avoid the use of any solvent different to the aqueous 382 
buffer, and dispersion of the extracts by mechanical procedures might be used instead, closer to a 383 
real physiological situation. Thus, the exploration of the effect of a simple shaking movement on 384 
the inhibitory activity of the extracts on pancreatic lipase was carried out. Due to the stronger 385 
inhibitory effect observed and to the higher content in TIC detected in both CEE of fenugreek and 386 
quinoa, the following assays were performed with those extracts only. 387 
As shown in Figure 3, the application of shaking to the samples did not lead to significant 388 
differences in neither of the IC50 values when compared to the assays in absence of shaking.  389 
However, it was observed a less variability in the IC50 values when shaking was applied. This result 390 
might be likely due to either a more adequate dispersion of the extracts in the buffer that did not 391 
occur in static conditions, as well to a better homogeneous interaction of all the components of the 392 
reaction, in general. Therefore, according to the obtained results, and in order to reach more 393 
reproducible results of in vitro measurement of inhibitory activities, the application of shaking 394 
procedures during the whole reaction might be recommended. Additionally, it was considered an 395 
interesting finding that the mechanical shaking of the aqueous environment of the enzymatic 396 
reaction did not impact on the magnitude of the inhibitory effects. Whether this lack of effect would 397 
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take place in a real in vivo situation under the peristaltic movements would be worthy for further 398 
evaluation.  399 
 400 
3.2.3 In vitro inhibitory effect under simulation of intestinal digestion 401 
Together with the movement of the enzymatic reaction environment, the simulation of other 402 
intestinal in vivo parameters should be considered essential in order to elucidate the potential 403 
inhibitory activity of compounds on digestive enzymes, especially presumable orally ingested 404 
compounds. Thus, a simple simulation of the in vitro intestinal digestion of the substrate by 405 
pancreatic lipase was performed. The major modification of the method was the inclusion of 406 
lecithin and bile salts in the enzymatic reaction, in order to simulate the components of the biliary 407 
secretion necessary during the in vivo intestinal digestion of lipids.  408 
According to Figure 3, the simulation of an in vitro intestinal digestion did cause a significant 409 
increase (p < 0.001) in the IC50 values of the extracts from both seeds (around 0.7 mg/mL for 410 
fenugreek extract and 2 mg/mL for quinoa extract), that is, a decrease in the lipase inhibition 411 
activity. Therefore, regardless of the seed, the inhibitory efficiency of the extracts against the 412 
pancreatic lipase activity was worse after simulation of intestinal conditions than by performing the 413 
traditional assay of inhibitory activity. 414 
The explanation of these results is complex, because either the activity of the lipase itself, the 415 
interaction between the components of the reaction, the modification of the components of the 416 
extracts, as well as a sum of all these reasons, might be involved in the observed effect. Lee et al. 417 
(2015) recently performed a similar approach as the present study, by comparing traditional method 418 
of inhibitory measurement, with the simulation of intestinal conditions for inhibitory measurement. 419 
In agreement with the findings of the present study, these authors also showed that, under 420 
simulation of intestinal conditions, extracts of black soya, black eye pea and red bean had a lower 421 
inhibitory activity against pancreatic lipase when compared to the inhibitory activity under in vitro 422 
traditional conditions. Only in the case of chickpea, the inhibitory activity did not differ between 423 
 
18 
both conditions. These authors attributed the results to the degradation of the bioactive compounds 424 
during the simulation of the intestinal digestion. On the other hand, Ercan & El (2016) evaluated the 425 
inhibitory activity of saponin extracts from chickpea and Tribulus terrestris against lipase after 426 
simulation of intestinal digestion by in vitro conditions. These authors found that such activity after 427 
the in vitro digestion was lower than the activity prior to digestion, which was associated to the pH 428 
of the media or the digestion process itself. Together with these previous reasons, the composition 429 
of the digestion buffer used in the present study might have also caused an increase in the lipase 430 
activity, acting the components of the buffer, such as bile salts, lecithin and calcium chloride as 431 
cofactors (McClements & Li, 2010). In this way, surface active materials are desorbed from the 432 
surfaces of emulsified lipids together with free fatty acids by bile salts and lecithin. This situation 433 
enables the lipase to keep adsorbed onto the surface of the emulsified lipids, enhancing its activity 434 
(Gargouri, Julien, Bois, Verger, & Sarda, 1983; Lee et al., 2015; Scow, 1988).  435 
According to all these previous evidences, and in order to evaluate whether the activity of the 436 
extracts might result modified during the time of reaction, the IC50 value of the extracts was also 437 
assessed at 60 min of reaction time, either under simulation of intestinal digestion and by the 438 
traditional method of inhibitory measurement. A significant effect of the time of reaction was found 439 
on the IC50 values (p = 0.028). Thus, in general, 60 min of reaction time led to higher IC50 values 440 
than 20 min of reaction time, that is, a worse inhibitory activity (Supplementary material). 441 
Therefore, longer reaction times hindered the inhibitory potential of the extracts, possibly due to a 442 
progressive degradation of the compounds responsible for such activity, as previously explained. 443 
Interestingly, this effect was independent on the used conditions to measure inhibition, as well as on 444 
the extract or seed.   445 
Finally, in order to evaluate the magnitude of the obtained IC50 values of the extracts, comparative 446 
assays with the commercial inhibitor Orlistat were performed and used as positive control under 447 
simulated intestinal conditions. The IC50 value was found to be 0.1 μg/mL. These extremely low 448 
IC50 values for Orlistat are usually found when this compound is tested by the traditional method. 449 
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Therefore, it is worthy to mention that finding such extremely low value for Orlistat when it is 450 
assayed under the method of simulating intestinal conditions would validate this last method as a 451 
correct procedure to test inhibitors of pancreatic lipase. This validation would allow to conclude 452 
that any result observed for the extracts during the simulation of intestinal digestion, would be due 453 
to the extracts, and that the generation of artifacts due to the method itself could be discarded. 454 
Comparing with the extracts, the IC50 value of Orlistat was considerably lower. Nevertheless, this 455 
was a reasonable result taking into account that Orlistat is a pure compound, whereas the assayed 456 
extracts consisted of a complex mixture of compounds, where only a minor part are potential 457 
inhibitors, and even potential enzymatic catalysts might not be discarded in the extracts. This is a 458 
typical situation observed when complex extracts are compared with pure inhibitors. In any case, 459 
and as general summary, it can be clearly concluded that all the assayed extracts from fenugreek 460 
and quinoa were inhibitors of the pancreatic lipase, in a dose-dependent manner, although 461 
fenugreek was superior, and that intestinal simulated conditions and long times of reaction may 462 
worsen the inhibitory activity of the extracts. Further in vivo studies would be necessary in order to 463 
effectively confirm that the oral intake of the extracts might interfere the digestion of dietary lipids 464 
and lead to a subsequent systemic health effect.   465 
 466 
3.3 Inhibitory effect against α-amylase 467 
3.3.1 Traditional method of in vitro inhibitory effect 468 
Similar to the pancreatic lipase assays, the inhibitory activity of the EE and CEE from fenugreek 469 
and quinoa against α-amylase was firstly evaluated under the traditional conditions (Figure 4). 470 
Although the traditional conditions can be variable, one of the most popular method is characterized 471 
by a simple in vitro incubation of the α-amylase enzyme with starch as substrate, in presence of the 472 
tested inhibitor, and in a proper phosphate buffer at 37ºC for 20 min. At the end of reaction, the 473 
absorbance due to the residual non-hydrolyzed starch is measured, and the comparison with the 474 
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absorbance measured in absence of inhibitor allows estimating the inhibitory activity (Ercan & El, 475 
2016; Podsędek et al., 2017).  476 
As shown in Figure 4, all the assayed extracts showed the ability to inhibit the α-amylase activity in 477 
a dose-dependent mode, but up to a maximum inhibitory dose. Thus, contrary to the lipase assays, a 478 
maximum inhibitory activity around 25% was reached in the best cases (EE and CEE fenugreek 479 
extracts and CEE quinoa extract), being not possible to estimate an inhibition of 50% of the activity 480 
for any of the extracts. Thus, for fenugreek, the highest inhibition was found at 3.3 mg/mL in both 481 
EE and CEE (25.6 ± 1% and 27.3 ± 2.9% inhibition, respectively), with no significant differences 482 
due to the extraction/concentration process. Additionally, in case of fenugreek extracts, even a 483 
decrease of the inhibitory activity was observed as the concentration of the extract increased. On the 484 
contrary, in the case of quinoa, the highest inhibition was found for the CEE extracts at 0.6 mg/mL 485 
(24.8 ± 1.7%), whereas at that same concentration, the EE exhibited almost no inhibition (0.29 ± 486 
0.1%) (p < 0.001). According to these results, it was clear that the ability to inhibit α-amylase 487 
activity of the extracts was much lower than the ability to inhibit pancreatic lipase. Furthermore, 488 
those extracts that were more effective for the inhibition of the lipase activity were not the same 489 
than those for the inhibition of α-amylase activity (fenugreek CEE and quinoa CEE, respectively).  490 
The inhibitory effect of fenugreek and quinoa extracts on α-amylase has been barely described in 491 
the literature. Similarly, Funke & Melzig (2006) described an inhibitory activity of amylase lower 492 
than 20% for fenugreek extracts obtained with boiling water. A water-soluble extract of fenugreek 493 
with an optimized phenolic content displayed an amylase inhibition index of approximately 1.15, 494 
that is, a very moderate inhibitory activity (McCue, Kwon, & Shetty, 2005). In the case of quinoa, 495 
Ranilla, Apostolidis, Genovese, Lajolo, & Shetty (2009) did not detect any inhibitory activity for 496 
aqueous extracts from either this seed or the other pseudocereals, cereals and legumes studied. 497 
Although Hemalatha, Bomzan, Sathyendra Rao, & Sreerama (2016) described a IC50 value of 0.16 498 
mg/mL for aqueous methanol extracts from whole grains of quinoa, which correlated with the 499 
phenolic content. 500 
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It is important to remark that the mild inhibitory activity of the assayed extracts on the α-amylase 501 
activity would not be a reason to consider this extracts as not worthy. As previously explained, a 502 
preferred strategy to control the release of glucose from disaccharides in the gut seems to be a 503 
moderate amylase inhibition together with a strong glucosidase inhibition (Ercan & El, 2016). This 504 
is because strong amylase inhibitors cause a subsequent abnormal fermentation of undigested 505 
saccharides in the colon, leading to gastrointestinal problems (Ercan & El, 2016; Nagmoti & 506 
Juvekar, 2013). Thus, it could be hypothesized that the moderate inhibitory activity of the tested 507 
extracts against amylase might be beneficial if stronger glucosidase inhibitory effects are 508 
demonstrated. In this sense, further studies would be necessary to analyze the effect of the extracts 509 
on glucosidase activity in order to evaluate the real potential of the extracts against carbohydrates 510 
digestion and absorption.  511 
 512 
3.3.2 Traditional method of in vitro inhibitory effect under shaking 513 
Due to the same reasons as stated previously for the lipase inhibition assays, the following two 514 
methods of inhibitory activity measurement were performed with the CEE only. Concerning the 515 
traditional method under shaking, and similar to the lipase assays, no significant differences were 516 
observed when applying shaking in neither of the seeds (p = 0.349 for fenugreek and p = 0.492 for 517 
quinoa) (Figure 5). Therefore, the movement of the aqueous environment of the enzymatic reaction 518 
did not impact on the magnitude of the inhibitory effects, as already observed for pancreatic lipase 519 
activity.  520 
 521 
3.3.3 In vitro inhibitory effect under simulation of intestinal digestion 522 
Surprisingly, under simulated intestinal conditions, the extracts from both seeds not only did not 523 
display any inhibitory activity against α-amylase, but even a slight catalysis of the enzyme was 524 
observed in a dose-dependent mode (Figure 5). The explanation of this result is complex, since in 525 
this case, the presence of lecithin and bile salts, as used in the method, is not relevant for the activity 526 
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of α-amylase. Further studies would be necessary in order to find and confirm an explanation to this 527 
result. In any case, it seems clear that under simulation of intestinal digestion, the inhibitory activity 528 
of extracts is more complicated to be evidenced, and even, contrary catalytic effects might appear.  529 
Concerning the effect of the time of reaction on the inhibitory activity of the extracts, the same 530 
trend as previously described for pancreatic lipase was also observed after 60 min of reaction time 531 
for amylase (data not shown), possibly due to the degradation of the inhibitor after a longer period 532 
of time. 533 
In the case of α-amylase, the commercial inhibitor acarbose was used as the positive control under 534 
simulated intestinal conditions. Contrarily to the extracts, the IC50 value for acarbose was 535 
effectively found, showing a value of 25 μg/mL. Similar to the previous explanation given for 536 
Orlistat in the case of lipase, finding an extremely low IC50 value for acarbose, similar to those 537 
found for the traditional method of measurement, would validate the method of simulation of 538 
intestinal digestion as a correct procedure to test inhibitors of α-amylase. Again, it would be 539 
possible to conclude that the poor results observed for the extracts during the simulation of 540 
intestinal digestion, would be due to the extracts, and that the generation of artifacts due to the 541 
method itself could be ruled out.  542 
As summary, it can be concluded that the inhibitory activity against α-amylase of both fenugreek 543 
and quinoa extracts was inexistent, and even slightly catalytic, when submitting them to simulated 544 
intestinal conditions, and that only mild inhibitory effect were observed in traditional assays. 545 
Further in vivo studies would be necessary in order to effectively confirm the real effect after oral 546 
intake of the extracts on the digestion of dietary carbohydrates and the subsequent systemic health 547 
effect.   548 
 549 
4. Conclusions 550 
Fenugreek extracts obtained by ethanol ultrasound assisted extraction, with a subsequent 551 
concentration procedure with butanol, are preferred than the ones from quinoa, considering the total 552 
 
23 
amount of potential inhibitor compounds of digestive enzymes, that is, saponins and phenolic 553 
compounds. Thus, all the assayed extracts from fenugreek and quinoa inhibit the digestive enzyme 554 
pancreatic lipase, but fenugreek extracts display a stronger inhibition likely due to their higher total 555 
inhibitors content. In any case, intestinal simulated conditions and longer times of reaction worsen 556 
the inhibitory activity of both extracts when compared to traditional methods of measurement. 557 
Concerning the inhibitory activity against α-amylase, both fenugreek and quinoa extracts display a 558 
mild inhibition by traditional methods of measurement, but a slightly catalytic effect is evidenced 559 
when submitting them to simulated intestinal conditions.  560 
These findings would confirm the importance of assessing the inhibitory activity of extracts against 561 
digestive enzymes under enzymatic conditions similar to those found in vivo in order to more 562 
realistically evaluate the potential of natural extracts. 563 
 564 
Abbreviations used 565 
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Ethanol Extract(s) 
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Figure Captions 689 
 690 
Figure 1. IC50 value (mg/mL) of ethanol extracts (EE) (lined bars) and concentrated ethanol extracts 691 
(CEE) (dotted bars) from fenugreek and quinoa against pancreatic lipase assayed under traditional 692 
conditions. (*) Values of IC50 for EE and CEE within each seed extract are significantly different (p 693 
≤ 0.05). 694 
 695 
Figure 2. Total inhibitors content (g/100 g) and IC50 value (mg/mL) against pancreatic lipase of 696 
ethanol extracts (EE) and concentrated ethanol extracts (CEE) from fenugreek (A) and quinoa (B). 697 
 698 
Figure 3. IC50 value (mg/mL) of CEE extracts of fenugreek and quinoa against pancreatic lipase 699 
assayed under traditional (horizontal lines), traditional with stirring (oblique lines) and simulated 700 
intestinal digestion (dots) conditions. 
a,b
 Different letters within a same seed are significantly 701 
different (p ≤ 0.05). 702 
 703 
Figure 4. Effect of concentration (mg/mL) of ethanol extracts (EE) (▲) and concentrated ethanol 704 
extracts (CEE) (■) from fenugreek and quinoa on the inhibition (%) of α-amylase assayed under 705 
traditional conditions. 706 
 707 
Figure 5. Effect of concentration (mg/mL) of CEE extracts from fenugreek (A) and quinoa (B) on 708 
the inhibition (%) of α-amylase assayed under traditional (▲), traditional with stirring (■) and 709 


















Table 1. Total saponin content (TSC), total phenolic content (TPC) and total 
inhibitor content (TIC) expressed as g per 100 g of extract.  
Seed Extract TSC TPC TIC 
Fenugreek    














   




 0.253 ± 0.019
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